ArticleFrontiers in immunology2026

Real-world efficacy and safety of transarterial chemoembolization plus sintilimab and bevacizumab biosimilar for intermediate-advanced hepatocellular carcinoma: a propensity score matching study.

Li-Wei Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.